Haoxi Health Technology Limited HAO
Annual
Quarterly
FY2026 · ended Jun 30, 2026 · Revenue $54.83M, +67.1% YoY · Filed Sep 30, 2026
Haoxi Health Technology Limited (HAO) files with the SEC under industry code 7311, Services-Advertising Agencies. In fiscal 2026, which ended Jun 30, 2026, it reported revenue of $54.8 million and a net loss of $9.5 million. As of Jun 30, 2026 it held $10.9 million in cash and investments and $1.6 million in total debt.
Revenue
$54.83M
+67.1% vs prior year
Net income
$-9.54M
-346.0% vs prior year
Operating cash flow
$-2.57M
+23.5% vs prior year
Free cash flow
$-802,943
EPS
$-386.40
-111.4% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$9.32M
FY 2026
Operating margin
-17.6%
FY 2026
Company profile
- Industry
- Services-Advertising Agencies (SIC 7311)
- Listed as
- HAO (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Cayman Islands
- Headquarters
- Beijing
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1954594
Other Services-Advertising Agencies companies
- Omnicom Group Inc. OMC
- WPP plc WPP
- Stagwell Inc STGW
- Criteo S.A. CRTO
- Groupon, Inc. GRPN
- TJGC GROUP Ltd TJGC
- Starco Brands, Inc. STCB
- Kidoz Inc. KDOZF
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jun 30, 2026 |
FY 2025 Jun 30, 2025 |
FY 2024 Jun 30, 2024 |
|---|---|---|---|
| Revenue | $54.8M | $32.8M | $48.5M |
| Operating income | -$9.7M | -$2.0M | $1.7M |
| Net income | -$9.5M | $3.9M | $1.3M |
| Diluted EPS | -$386.40 | $3,385.53 | $2,701.53 |
| Operating cash flow | -$2.6M | -$3.4M | -$747,576 |
| Free cash flow | — | — | -$802,943 |
| Total assets | $21.6M | $21.6M | $15.5M |
| Total liabilities | $3.7M | $4.2M | $4.2M |
| Stockholders' equity | $17.9M | $17.4M | $11.3M |
| Cash and investments | $10.9M | — | $6.7M |
| Total debt | $1.6M | $2.0M | $1.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Sep 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 13, 2026 | Jul 13, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 6, 2026 |
| 6-K | Current report (foreign issuer) | Jun 24, 2026 | Jun 24, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 21, 2026 |
All 105 Haoxi Health Technology Limited SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.